The plaque of National Facility for Regenerative Medicine at AIIMS was unveiled on January 12, 2015 by Dr Chandan Sen.
The Ohio State University (OSU), second largest public research university in the United States, in association with AIIMS, New Delhi announced commencement of first H3C Health Sciences Innovation Conference in India. The first day of the conference witnessed multi-stakeholder discussion around regenerative medicine, nanotechnology and wound care. The conference is chaired by Prof Chandan K. Sen, a key leader at The Ohio State University and a scientist of Indian Origin.
The Ohio State University pioneers in regenerative medicine providing strong inputs for the proposed centre in Delhi at the AIIMS campus, for which the Indian Council for Medical Research (ICMR) and the Department of Biotechnology (DBT) will be approached for funding. The conference explored opportunity to build international collaboration networks to jointly apply for these new international funding sources through many funding opportunities.
Co chaired by Prof Amit K Dinda MD, PhD, professor, Department of Pathology, AIIMS, the conference witnessed participation from eminent dignitaries like Dr Maneesh Singhal, FACS, AIIMS; and Prof Mahesh C. Misra, director, AIIMS.
The spotlight was on fostering industry relationships by inviting Indian industries towards R&D partnership - from basic sciences to clinical trials. The other pivotal aspects of this conference were to look at opportunities in vascular biology, neuroscience, material science, regenerative medicine and cord blood banking.
Commenting on the occasion, Dr Chandan Sen, PhD, director of the Centre for Regenerative Medicine and Cell-Based Therapies at The Ohio State University said, "We are delighted to collaborate with AIIMS (India) as not only does it offer immense opportunities for co-operation but we can learn so much from the Indian experience given the breath and volume of cases and specific needs. At the same time we offer several sets of scientific expertise to enrich the new program at AIIMS."
This conference will enable Ohio State faculty to meet colleagues with similar interests, discuss the latest technologies and share and exchange ideas for potential research collaborations not only with academic institutions but also with biotech and pharmaceutical companies, and hospital and health care systems. It is an exciting opportunity for research engagement," he said.
